Search AI Products and News

Hangzhou-based medical AI company, MeiYin Intelligence Technology Co., Ltd., recently announced it has secured millions of yuan in seed funding. The funding will primarily be used for R&D and commercialization of its core product. The round was led by Zhuoyuan Asia, with participation from Xihu Government Direct Investment Fund. MeiYin Intelligence focuses on leveraging AI to predict disease risk and promote health management. Its core product, based on its self-developed DP-LLM large model, supports the processing of multimodal medical data to accurately quantify an individual's future disease risk, covering hundreds of diseases and more.

Recent reports indicate that vivo has established a Robotics LAB, focusing on the incubation and R&D of robotic products, particularly in the home robotics sector. This has drawn significant industry attention. While responding to inquiries from the Daily Economic News, vivo confirmed the news as a normal business adjustment, hinting that more details on their robotics business will be unveiled at the upcoming Boao Forum for Asia. In fact, vivo has shown a strong interest in the robotics industry for some time. In December 2023, vivo...

Glaucoma, the 'silent thief of sight,' threatens the vision of 26 million people in China. But now, a breakthrough has arrived. 'Xiao Qing,' a powerful AI tool, has been launched in collaboration with leading Chinese medical institutions to combat glaucoma and restore hope for patients. Recently, a 'Glaucoma Chronic Disease Management Center' was launched in Shanghai, a joint initiative of 12 top-tier hospitals including Fudan University Affiliated Eye, Ear, Nose, and Throat Hospital, Sun Yat-sen University Zhongshan Ophthalmic Center, and Beijing Tongren Hospital.

A groundbreaking AI-powered ultrasound technology has won a million-dollar prize, promising a revolution in heart health diagnostics and paving the way for more accessible and accurate cardiac care.

vivo recently announced a gray-scale update (version 5.2.1.22) to its "Blue Heart Little V" voice assistant, incorporating DeepSeek large model capabilities. This highly anticipated update enables "Little V" to offer more intelligent and in-depth thinking, assisting users in better information processing. User feedback indicates that with the deep thinking (R1) function enabled, "Blue Heart Little V" can conduct more comprehensive and thorough analysis based on user input commands.

A significant advancement in Chinese medicine has been achieved with the recent clinical deployment of "Xiehe-Taichu," a rare disease AI model jointly developed by Peking Union Medical College Hospital and the Institute of Automation, Chinese Academy of Sciences. This marks a breakthrough in China's rare disease diagnostic technology and provides a new tool for improving clinical efficiency. The development of this AI model benefits from years of accumulated knowledge on rare diseases in China and the support of genetic testing data from the Chinese population. As the world's first rare disease model tailored to the characteristics of the Chinese population, it...

Recently, the Evo2 bio AI model, jointly developed by Arc Institute and Nvidia, was officially released. This foundational model is based on DNA data from over 100,000 species and aims to deeply decode various complex phenomena in biology. Evo2 can identify patterns in the genetic sequences of different organisms that researchers would typically take years to discover, significantly enhancing the ability to identify disease-related mutations, and can design entirely new genomes comparable to simple bacteria.

Recently, a user on Reddit shared a remarkable experience, claiming that the AI chatbot ChatGPT provided crucial assistance during a life-threatening situation by promptly diagnosing a rare kidney disease. The post quickly went viral, attracting significant attention and discussion among users. The user, with the username 'Ananymous717', reported feeling unusually unwell after what seemed like a simple workout. He recalled, 'About a week ago, I did a workout that I thought was low in intensity, but when I woke up...'

The research team from The Chinese University of Hong Kong (Shenzhen) and Shenzhen Big Data Institute has recently launched a medical large language model (LLM) named HuatuoGPT-o1. This model is specifically designed for complex reasoning in the medical field, aiming to enhance the reliability of medical diagnosis and decision-making. Unlike previous LLMs that focused on mathematical reasoning, HuatuoGPT-o1 specializes in the medical domain by simulating the rigorous thought processes of doctors in real-world practice, paving new avenues for the development of medical AI.

As we have discussed in this blog, artificial intelligence has made significant advancements in areas such as image generation and writing. However, when it comes to creating music that truly resonates with the heart, AI faces considerable challenges. While AI music generators can produce competent melodies, their works often feel hollow and disconnected from the unique human experience that defines music. YouTube channel creator Adam Neely analyzes the dilemmas AI encounters in music composition in his videos. The 'hard flaw' of AI music: lack of emotion.